A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients.

Guan JT, Wang WJ, Jin D, Mou XY, Lei SS, Xu ZH

Open source

DOI
10.1177/20406223211039699
Published
2021
Container
Therapeutic advances in chronic disease
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/20406223211039699,
  title = {A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients.},
  author = {Guan JT and Wang WJ and Jin D and Mou XY and Lei SS and Xu ZH},
  year = {2021},
  journal = {Therapeutic advances in chronic disease},
  doi = {10.1177/20406223211039699},
  url = {https://doi.org/10.1177/20406223211039699}
}

RIS

TY  - JOUR
TI  - A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients.
AU  - Guan JT
AU  - Wang WJ
AU  - Jin D
AU  - Mou XY
AU  - Lei SS
AU  - Xu ZH
PY  - 2021
JO  - Therapeutic advances in chronic disease
DO  - 10.1177/20406223211039699
UR  - https://doi.org/10.1177/20406223211039699
ER  - 

APA

JT, G., WJ, W., D, J., XY, M., SS, L., & ZH, X. (2021). A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients.. Therapeutic advances in chronic disease. https://doi.org/10.1177/20406223211039699

Source records